CLM
LXRX icon

ClearBridge LLC (Maryland)’s Lexicon Pharmaceuticals LXRX Stock Holding History

ClearBridge LLC (Maryland)’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,299,917
Closed -$15.6K – 131
2018
Q2 		$15.6K Buy
1,299,917
+127,800
+11% +$1.31M 0.26% 96
2018
Q1 		$10M Sell
1,172,117
-16,980
-1% -$157K 0.22% 124
2017
Q4 		$11.7M Buy
1,189,097
+313,350
+36% +$3.26M 0.24% 115
2017
Q3 		$10.8M Buy
875,747
+73,380
+9% +$1.08M 0.23% 111
2017
Q2 		$13.2M Buy
802,367
+82,337
+11% +$1.27M 0.28% 90
2017
Q1 		$10.3M Buy
+720,030
New +$10.7M 0.22% 100

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
SGA
Sector Gamma AS Oslo, Norway $423M AUM 17.56% 1-Year Est. Return

ClearBridge LLC (Maryland)'s LXRX Position: Q3 2018 in Review

ClearBridge LLC (Maryland) sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2018, closing a stake of 1,299,917 shares — an estimated $15.6K sold.

ClearBridge LLC (Maryland) first reported a position in LXRX in Q1 2017 and held it in 6 quarters. The position peaked at $13.2M in Q2 2017. 119 funds tracked by Wall St. Rank hold LXRX as of Q3 2018.

  • ClearBridge LLC (Maryland) reported no remaining Lexicon Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • ClearBridge LLC (Maryland) sold 1,299,917 Lexicon Pharmaceuticals shares in Q3 2018, an estimated $15.6K.
  • ClearBridge LLC (Maryland) first reported a position in Lexicon Pharmaceuticals in Q1 2017 and held it in 6 quarters.
  • ClearBridge LLC (Maryland)'s Lexicon Pharmaceuticals position peaked at $13.2M in Q2 2017.
  • 119 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2018.

Based on ClearBridge LLC (Maryland)'s 13F filing for Q3 2018, filed 14 Nov 2018.